Cardiometabolic Risk of Obese Subjects: Cross-sectional Study
Recruiting · NCT06714058 · Observational (researchers observe without assigning treatment) · Lead sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
View the official record on ClinicalTrials.gov →What this trial is about
experimental study with analysis on tissues. This study aims to study cardiometabolic risk from a genetic, clinical, instrumental and laboratory point of view in a population of subjects with obesity.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- • Age \> 18 years
- BMI \> 30 Kg/m2
- In primary prevention for cardiovascular disease
- Ability to communicate, make themselves understood and adhere to study-specific procedures
- Willingness to participate in the study and obtain informed consent
Exclusion criteria
- Patients already enrolled by the Research Units involved in the enrolment
- Glycated hemoglobin level \> 55 mmol/L
- Patients suffering from obesity secondary to endocrinological diseases or iatrogenic causes
- Patients with heterozygous Familial Hypercholesterolemia (Dutch Lipid Score - DLS\>8)
- Patients suffering from hypercholesterolemia secondary to lipid or iatrogenic extra-metabolic pathologies
- Patients suffering from systemic inflammatory or oncological diseases
- Patients on active treatment with GLP-1 analogues
- Pregnancy and breastfeeding
- Any medical or surgical condition that makes the patient's adherence to the study protocol complex or inconsistent.
Where it is running
2 locations listed.
- Azienda Ospedaliero-Universitaria "Renato Dulbecco" di Catanzaro - Catanzaro, Italy
- Maria Letizia Petroni - Bologna, BO, Italy